362 related articles for article (PubMed ID: 31692111)
21. Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa.
Slater SD; McGrath JA; Hobbs C; Eady RA; McKee PH
Histopathology; 1992 Mar; 20(3):237-41. PubMed ID: 1563710
[TBL] [Abstract][Full Text] [Related]
22. Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis.
Csikós M; Orosz Z; Bottlik G; Szöcs H; Szalai Z; Rozgonyi Z; Hársing J; Török E; Bruckner-Tuderman L; Horváth A; Kárpáti S
Clin Exp Dermatol; 2003 Mar; 28(2):163-6. PubMed ID: 12653705
[TBL] [Abstract][Full Text] [Related]
23. Successful use of immunotherapy to treat advanced cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Duong T; Wong D; Barrett A; Price H
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33637494
[TBL] [Abstract][Full Text] [Related]
24. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Santucci C; Alexandru M; Chen X; Mellerio JE; Karagiannis SN; Jacków-Malinowska J
Hum Immunol; 2024 May; 85(3):110805. PubMed ID: 38703415
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.
Robertson SJ; Orrin E; Lakhan MK; O'Sullivan G; Felton J; Robson A; Greenblatt DT; Bernardis C; McGrath JA; Martinez AE; Mellerio JE
Acta Derm Venereol; 2021 Aug; 101(8):adv00523. PubMed ID: 34230977
[TBL] [Abstract][Full Text] [Related]
26. Dominant dystrophic epidermolysis bullosa with congenital absence of skin and brachydactyly of the great toes.
Sawka E; Funk T
Pediatr Dermatol; 2021 Sep; 38(5):1251-1254. PubMed ID: 34338359
[TBL] [Abstract][Full Text] [Related]
27. Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.
Welponer T; Weber DD; Trattner L; Tockner B; Aminzadeh-Gohari S; Leb-Reichl V; Kaufmann A; Zauner R; Wimmer M; Wally V; Felder TK; Strunk D; Koller U; Bauer JW; Kofler B; Guttmann-Gruber C; Piñon Hofbauer J
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):112-123. PubMed ID: 37669776
[TBL] [Abstract][Full Text] [Related]
28. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma.
Ayman T; Yerebakan O; Ciftçioglu MA; Alpsoy E
Pediatr Dermatol; 2002; 19(5):436-8. PubMed ID: 12383103
[TBL] [Abstract][Full Text] [Related]
29. Dystrophic Epidermolysis Bullosa.
Yadav RS; Jayswal A; Shrestha S; Gupta SK; Paudel U
JNMA J Nepal Med Assoc; 2018; 56(213):879-882. PubMed ID: 31065125
[TBL] [Abstract][Full Text] [Related]
30. Electrochemotherapy, a potential new treatment for the management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases.
Diociaiuti A; Rotunno R; El Hachem M; Latorre S; Cozza R; Curatolo P
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1195-6. PubMed ID: 25758658
[No Abstract] [Full Text] [Related]
31. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Arbiser JL; Fine JD; Murrell D; Paller A; Connors S; Keough K; Marsh E; Folkman J
Mol Med; 1998 Mar; 4(3):191-5. PubMed ID: 9562977
[TBL] [Abstract][Full Text] [Related]
32. Predominance of Staphylococcus Correlates with Wound Burden and Disease Activity in Dystrophic Epidermolysis Bullosa: A Prospective Case-Control Study.
Reimer-Taschenbrecker A; Künstner A; Hirose M; Hübner S; Gewert S; Ibrahim S; Busch H; Has C
J Invest Dermatol; 2022 Aug; 142(8):2117-2127.e8. PubMed ID: 35149000
[TBL] [Abstract][Full Text] [Related]
33. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa: report of eight tumours in four patients.
Bosch RJ; Gallardo MA; Ruiz del Portal G; Snchez P; Arce MF; Herrera E
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):198-204. PubMed ID: 10642056
[TBL] [Abstract][Full Text] [Related]
34. [Squamous cell carcinoma complicating an hereditary epidermolysis bullosa].
Mseddi M; Turki H; Marrekchi S; Abdelmaksoud W; Masmoudi A; Bouassida S; Zahaf A
Cancer Radiother; 2004 Aug; 8(4):266-9. PubMed ID: 15450521
[TBL] [Abstract][Full Text] [Related]
35. Wound closure by secondary intention is successful in the treatment of squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Rodríguez-Lojo R; Fernández-Jorge B; DE Andrés A; Peña C; García-Silva J
Eur J Dermatol; 2011; 21(2):302-3. PubMed ID: 21540143
[No Abstract] [Full Text] [Related]
36. Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study.
Bremer J; Pas HH; Diercks GFH; Meijer HJ; van der Molen SM; Nijenhuis AM; van Nijen-Vos LL; Morandé P; Yubero MJ; Palisson F; Fuentes I; Pasmooij AMG
Exp Dermatol; 2024 Feb; 33(2):e15035. PubMed ID: 38389191
[TBL] [Abstract][Full Text] [Related]
37. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient.
Tomita Y; Sato-Matsumura KC; Sawamura D; Matsumura T; Shimizu H
Acta Derm Venereol; 2003; 83(3):225-6. PubMed ID: 12816163
[No Abstract] [Full Text] [Related]
39. Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures.
Stricklin GP; Welgus HG; Bauer EA
J Clin Invest; 1982 Jun; 69(6):1373-83. PubMed ID: 6282934
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneous addiction to transforming growth factor-beta signalling in recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma.
Dayal JHS; Mason SM; Salas-Alanis JC; McGrath JA; Taylor RG; Mellerio JE; Blyth K; South AP; Inman GJ
Br J Dermatol; 2021 Apr; 184(4):697-708. PubMed ID: 32726455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
